|
|
Line 288: |
Line 288: |
| ====Seminal vesicle invasion==== | | ====Seminal vesicle invasion==== |
| :Abbreviated ''SVI''. | | :Abbreviated ''SVI''. |
| General:
| | {{Main|Prostate cancer staging#Seminal vesicle invasion}} |
| *Typically upstages to pT3b.
| |
| *Associations:<ref name=pmid23194127>{{Cite journal | last1 = Sapre | first1 = N. | last2 = Pedersen | first2 = J. | last3 = Hong | first3 = MK. | last4 = Harewood | first4 = L. | last5 = Peters | first5 = J. | last6 = Costello | first6 = AJ. | last7 = Hovens | first7 = CM. | last8 = Corcoran | first8 = NM. | title = Re-evaluating the biological significance of seminal vesicle invasion (SVI) in locally advanced prostate cancer. | journal = BJU Int | volume = 110 Suppl 4 | issue = | pages = 58-63 | month = Dec | year = 2012 | doi = 10.1111/j.1464-410X.2012.11477.x | PMID = 23194127 }}</ref>
| |
| **Most SVI is by direct extension ~90%.
| |
| **Approximately 20% of patients with pT3x have SVI.
| |
| **Usually associated with a large tumour volume (22% versus 12%).
| |
| | |
| Microscopic:
| |
| *Tumour '''must''' be in the muscle surrounding the epithelial component; tumour in the adventitia (the loose connective tissue surrounding the seminal vesicles) does not count.<ref name=Ref_Lester3_409>{{Ref Lester3|409}}</ref><ref name=pmid20818343>{{Cite journal | last1 = Berney | first1 = DM. | last2 = Wheeler | first2 = TM. | last3 = Grignon | first3 = DJ. | last4 = Epstein | first4 = JI. | last5 = Griffiths | first5 = DF. | last6 = Humphrey | first6 = PA. | last7 = van der Kwast | first7 = T. | last8 = Montironi | first8 = R. | last9 = Delahunt | first9 = B. | title = International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes. | journal = Mod Pathol | volume = 24 | issue = 1 | pages = 39-47 | month = Jan | year = 2011 | doi = 10.1038/modpathol.2010.160 | PMID = 20818343 }}</ref>
| |
| | |
| Notes:
| |
| *Invasion of the adventitia (only) would quality as EPE; this is, usually, T3a.
| |
| *Immunostains useful to separate prostate carcinoma from [[SV]] are discussed in the ''[[seminal vesicle]]'' article.
| |
| *It is not possible to differentiate the ''seminal vesicles'' and ''ejaculatory ducts'' based only on histology; thus, on biopsy one can generally comment only on ''seminal vesicle/ejaculatory duct invasion''.
| |
|
| |
|
| ====Lymph node metastases==== | | ====Lymph node metastases==== |